Recent Finacing
Recent Raise
SignaCor Therapeutics is a Belfast-based clinical-stage biotech developing a first-in-class DNA-methylation therapy to reverse heart damage and slow hypertrophic cardiomyopathy.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at SignaCor Therapeutics.
